Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial

References

• Blasi F, Mantero M, Santus P, Tarsia P. Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect. 2012;18(Suppl 5):7–14. doi:10.1111/j.1469-0691.2012.03937.x.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza — United States, 1976–2007. MMWR Morb Mortal Wkly Rep. 2010;59:1057–62. PMID:20798667.
   PubMedGoogle Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013:CD000422.
   Google Scholar
• Kohlhammer Y, Schnoor M, Schwartz M, Raspe H, Schafer T. Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Public Health. 2007;121:742–51. doi:10.1016/j.puhe.2007.02.011. PMID:17572457
   PubMed Web of Science ®Google Scholar
• Public Health England. Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2014 to March 2015. Health Protection Report. 2015. Available at https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/448406/hpr2615_ppv.pdf. ( Accessed Dec 21, 2017).
   Google Scholar
• National Center for Health Statistics. 2016. Early release of selected estimates based on data From the January–June 2016 National Health Interview Survey. https://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201611.pdf ( accessed Dec 21, 2017).
   Google Scholar
• Poethko-Muller C, Schmitz R. Vaccination coverage in German adults: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:845–57. PMID:23703506
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. 2017. Influenza vaccination rates (indicator) https://data.oecd.org/healthcare/influenza-vaccination-rates.htm. ( accessed Dec 21, 2017).
   Google Scholar
• National Center for Immunization and Respiratory Diseases. General recommendations on immunization — recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60:1–64.
   PubMedGoogle Scholar
• Christenson B, Hedlund J, Lundbergh P, Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J. 2004;23:363–8. doi:10.1183/09031936.04.00063504. PMID:15065822
   PubMed Web of Science ®Google Scholar
• Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, Koyama K, Harada Y, Iwanaga K, Yamaryo T, Oishi K. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine. 2010;28:7063–9. doi:10.1016/j.vaccine.2010.08.010. PMID:20723631
   PubMed Web of Science ®Google Scholar
• Grilli G, Fuiano L, Biasio LR, Pregliasco F, Plebani A, Leibovitz M, Ugazio AG, Vacca F, Profeta ML. Simultaneous influenza and pneumococcal vaccination in elderly individuals. Eur J Epidemiol. 1997;13:287–91. doi:10.1023/A:1007398606807. PMID:9258527
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8:81–88. doi:10.4161/hv.8.1.17623. PMID:22252006
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11:760–8. doi:10.1016/S1473-3099(11)70090-1. PMID:21621466
   PubMed Web of Science ®Google Scholar
• Musher DM, Manof SB, Liss C, McFetridge RD, Marchese RD, Bushnell B, Alvarez F, Painter C, Blum MD, Silber JL. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis. 2010;201:516–24. doi:10.1086/649839. PMID:20092407
   PubMed Web of Science ®Google Scholar
• Chiba N, Morozumi M, Sunaoshi K, Takahashi S, Takano M, Komori T, Sunakawa K, Ubukata K, IPD Surveillance Study Group. Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect. 2010;138:61–68. doi:10.1017/S0950268809990239. PMID:19538821
   PubMed Web of Science ®Google Scholar
• Gilchrist SA, Nanni A, Levine O. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. Am J Public Health. 2012;102:596–605. doi:10.2105/AJPH.2011.300512. PMID:22397339
   PubMed Web of Science ®Google Scholar
• Hung IF, Leung AY, Chu DW, Leung D, Cheung T, Chan CK, Lam CL, Liu SH, Chu CM, Ho PL, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis. 2010;51:1007–16. doi:10.1086/656587. PMID:20887208
   PubMed Web of Science ®Google Scholar
• Fletcher TJ, Tunnicliffe WS, Hammond K, Roberts K, Ayres JG. Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease. BMJ. 1997;314:1663–5. doi:10.1136/bmj.314.7095.1663. PMID:9193290
   PubMedGoogle Scholar
• DeStefano F, Goodman RA, Noble GR, McClary GD, Smith SJ, Broome CV. Simultaneous administration of influenza and pneumococcal vaccines. JAMA. 1982;247:2551–4. doi:10.1001/jama.1982.03320430055032.
   Web of Science ®Google Scholar
• Carlson AJ, Davidson WL, McLean AA, Vella PP, Weibel RE, Woodhour AF, Hilleman MR. Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine. Proc Soc Exp Biol Med. 1979;161:558–63. doi:10.3181/00379727-161-40596. PMID:39297
   PubMed Web of Science ®Google Scholar
• Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999–2011(1.). Emerg Infect Dis. 2013;19:1074–83. doi:10.3201/eid1907.121830. PMID:23763847
   PubMed Web of Science ®Google Scholar
• Socan M, Frelih T, Janet E, Petras T, Peternelj B. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine. Vaccine. 2004;22:3087–91. doi:10.1016/j.vaccine.2004.02.003. PMID:15297059
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Nahm MH, Han MK, Harnden S, Criner GJ, Martinez FJ, Scanlon PD, Woodruff PG, Washko GR, Connett JE, et al. Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:499–505. doi:10.1164/rccm.200903-0488OC. PMID:19556517
   PubMed Web of Science ®Google Scholar
• Mori S, Ueki Y, Akeda Y, Hirakata N, Oribe M, Shiohira Y, Hidaka T, Oishi K. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis. 2013;72:1362–6. doi:10.1136/annrheumdis-2012-202658. PMID:23345600
   PubMed Web of Science ®Google Scholar
• Oishi K, Yoshimine H, Watanabe H, Watanabe K, Tanimura S, Kawakami K, Iwagaki A, Nagai H, Goto H, Kudoh S, et al. Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan. Respirology. 2006;11:429–36. doi:10.1111/j.1440-1843.2006.00867.x. PMID:16771912
   PubMed Web of Science ®Google Scholar
• Marchese RD, Puchalski D, Miller P, Antonello J, Hammond O, Green T, Rubinstein LJ, Caulfield MJ, Sikkema D. Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum. Clin Vaccine Immunol. 2009;16:387–96. doi:10.1128/CVI.00415-08. PMID:19158284
   PubMed Web of Science ®Google Scholar
• Hirst GK. The quantitative determination of influenza virus and antibodies by means of red cell agglutination. J Exp Med. 1942;75:49–64. doi:10.1084/jem.75.1.49. PMID:19871167
   PubMedGoogle Scholar
• Cordonnier C, Labopin M, Chesnel V, Ribaud P, De La Camara R, Martino R, Ullmann AJ, Parkkali T, Locasciulli A, Yakouben K. et al. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis. 2009;48:1392–401. doi:10.1086/598324. PMID:19368505
   PubMed Web of Science ®Google Scholar